Wed, Jul 23, 2014, 12:49 PM EDT - U.S. Markets close in 3 hrs 11 mins


% | $
Click the to save as a favorite.

Geron Corporation (GERN) Message Board

  • gosmokeadoobie gosmokeadoobie Mar 26, 2013 8:58 PM Flag

    Imetelstat in Treating Young Patients With Lymphoma

    Children's Oncology Group
    National Cancer Institute (NCI)

    A Phase I Study of Imetelstat, a Telomerase Inhibitor, in Children With Refractory or Recurrent Solid Tumors and Lymphomas

    Estimated Enrollment: 45
    Study Start Date: May 2011
    Estimated Primary Completion Date: January 2015 (Final data collection date for primary outcome measure)

    Primary Outcome Measures:

    Maximum-tolerated dose and/or recommended phase II dose of imetelstat sodium in children with refractory or recurrent solid tumors or lymphoma [ Designated as safety issue: Yes ]
    Toxicities of imetelstat sodium [ Designated as safety issue: Yes ]

    SortNewest  |  Oldest  |  Most Replied Expand all replies
2.54-0.05(-1.93%)12:49 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.